ExpoPharm Pre-Event
OMMAX Events

Expopharm pre-event

From Dr. Google to Dr. AI: What changing patient behavior means for healthcare and pharmacies. Ahead of Expopharm 2026, OMMAX brought together leading voices from pharmacy, pharma, medical care and cybersecurity to discuss how AI is reshaping patient behavior, healthcare access and trust.

Large Language Models are becoming a new point of contact for patients, changing how they search for health information, prepare for consultations and make decisions. At the same time, expectations around convenience, accessibility and digital healthcare experiences continue to rise.

In the context of Expopharm 2026, OMMAX brought together leaders from pharmacy, pharma, healthcare, medical care and cybersecurity at its Munich headquarters to discuss what this shift means for the future of healthcare.

About the event

Under the theme “From Dr. Google to Dr. AI”, the evening explored a fundamental question: What happens when patients increasingly turn to AI before speaking to a pharmacist or physician?

The discussion brought together perspectives from across the healthcare ecosystem, from direct patient care and pharmacy to the pharmaceutical industry and cybersecurity.

The conversation showed that the impact of AI goes far beyond a new search interface. It is changing how informed patients are when they enter a pharmacy or practice, how healthcare organizations need to think about digital visibility and how trusted human expertise needs to evolve alongside increasingly capable AI systems.

Five key takeaways

  1. Patient behavior has already shifted
    Patients are increasingly using AI to research symptoms, understand health topics and prepare for conversations with healthcare professionals. Instead of arriving with an open question, they may already have an AI-generated assessment, recommendation or suggested next step.
  2. Healthcare professionals are moving from information to interpretation
    Greater access to information does not eliminate the need for pharmacists and physicians. Their role becomes even more important in contextualizing information, assessing its relevance for the individual and distinguishing reliable guidance from potentially misleading recommendations.
  3. AI visibility is becoming a commercial priority for pharma
    As AI platforms increasingly influence the first stages of the patient journey, healthcare and pharmaceutical organizations need to consider whether their trusted information can be found, understood and correctly contextualized by AI systems.
  4. The future of healthcare requires connected patient journeys
    The discussion moved beyond the question of which healthcare professional should perform which task. The bigger opportunity lies in creating connected pathways across pharmacies, medical practices and other healthcare providers, supported by better data availability and interoperability.
  5. Cybersecurity must be built in from the start
    More connected healthcare and increasing AI adoption also create new attack surfaces. Protecting sensitive patient and health data cannot be an afterthought. Security by design needs to become a fundamental principle of digital healthcare transformation.
ExpoPharm Pre-Event

Speakers

Dr. Anja Konhäuser
Founding Partner, OMMAX

Perspective on AI-driven patient journeys, digital healthcare transformation and the implications of AI for healthcare organizations.

Dr. Ina Lucas
Vice President, ABDA | Pharmacist

Perspective on patient behavior, the evolving role of community pharmacies and the pharmacy as an accessible, connected healthcare hub.

Arwid Zang
CEO & Founder, greenhats | Cybersecurity Expert

Perspective on cybersecurity, new digital attack surfaces and the protection of sensitive health and patient data.

Lutz Boden
Managing Director OTC Market, Pharma Deutschland e.V. | Pharmacist

Perspective on the pharmaceutical industry, self-medication, regulation and the growing importance of trusted information in AI-driven patient journeys.

Dr. med. Markus Frühwein
Physician & Owner, Praxis Dr. Frühwein & Partner

Perspective on ambulatory care, prevention, digitalization in medical practice and the evolving relationship between patients and healthcare professionals.

ExpoPharm Pre-Event 2026

Looking ahead

The question is no longer whether patients will use AI for health-related information. They already do.

The more important question is how pharmacies, physicians, pharmaceutical companies and technology providers can shape this development so that more information ultimately leads to better healthcare.

At OMMAX, we support healthcare and life sciences organizations in translating AI, data and digital transformation into measurable impact, from AI visibility and patient journeys to operating models, technology and implementation.

ExpoPharm Pre-Event 2026
ExpoPharm Pre-Event 2026

Event speakers

Dr. Anja Konhäuser

Dr. Anja Konhäuser

Founding Partner
Profile
Ina Lucas

Dr. Ina Lucas

Vice President, ABDA
Arwid Zang

Arwid Zang

CEO & Founder, greenhats
Lutz Boden

Lutz Boden

Managing Director OTC Market, Pharma Deutschland
Dr. Markus Frühwein

Dr. med. Markus Frühwein

Inhaber & Arzt, Praxis Dr. Frühwein & Partner

Time and Location

Munich
September 14, 2026 | 6PM
OMMAX HQ (Kaulbachstraße 4, 80539 Munich)
Get in touch

Want to discuss what AI-driven patient behavior means for your organization?
Get in touch with our Healthcare & Life Sciences experts!

Dr. Anja Konhäuser

Dr. Anja Konhäuser

Founding Partner

Sandra Welchering

Sandra Welchering

Partner

Lyn Welsch

Lyn Welsch

Vice President Digital Strategy

Alexander Porsche

Alexander Porsche

Director Digital Strategy